Bio-Rad Reports First-Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
- S&P 500 ends down as oil tops $100 per barrel
- Trump promises $5,000 payout to U.S. adults if Republicans win election
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Rogers adds Sportsnet+ content to Xfinity TV packages for free
- White House copper tariff plan stalls amid affordability concerns, sources say
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Bio-Rad Labs (BIO) Tops Q1 EPS by 5c, Beats on Revenue; Offers Guidance
April 30, 2026 4:24 PM EDTBio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.89, $0.05 better than the analyst estimate of $1.84. Revenue for the quarter came in at $592.1 million versus the consensus estimate of $586.97 million.
Bio-Rad is updating its financial outlook for the full-year 2026. The Company currently expects non-GAAP,... More
